Background: C-reactive protein is a biomarker among the spontaneous intracerebral haemorrhage patients. Objective: The purpose of this present study was to see the association of CRP level with the short term clinical outcome among spontaneous intracerebral haemorrhage patients. Methodology: This prospective cohort study was conducted in the Department of Neurology at Dhaka Medical College and Hospital, Dhaka, Bangladesh from July 2012 to June 2014 for a period of two (02) years. Patients presented with first ever spontaneous intracerebral haemorrhage with the age group of more than or equal to 18 years with both sexes and hospital admission within 48 hours of onset were included for this study. Admission plasma CRP was measured and study population were divided into group I (plasma CRP≥6 mg/L) and group II (plasma CRP<6 mg/L). The patients were observed daily till 1 week after admission with special attention to vital parameters and clinical outcome which were mortality, functional outcome and early neurological worsening. Finally findings were analyzed and clinical outcome were compared in patient with different level of admission plasma CRP. Result: Early neurological worsening at the end of first week was 37(38%) patients. Poor functional outcome (GOS 2-3) at the end of first week was found in 51(52%) patients. Overall mortality within that period was 16(17%) patients. Elevated CRP level was associated with higher proportion of GCS score < 9 at day seven. Early neurological worsening and poor functional outcome (GOS2-3) was also found more in these patients. Conclusion: High admission plasma CRP level may be associated with higher proportions of poor short term outcome (GOS 2-3), early neurological worsening at the end of the first week after onset and mortality within this period in the patients with spontaneous intracerebral haemorrhage.
Introduction
Inflammation is a major feature of spontaneous intracerebral hemorrhage (sICH) pathology 1 and involved in the progression of brain injury after sICH 2 .
Inflammatory markers on admission, such as fever, elevated white blood cell (WBC) count, interleukin-6 (IL-6), and fibrinogen are associated with worse short-term outcome 3 . Pathologic mechanisms include immunologic, endothelial dysfunction, and coagulopathy, contributing to morbidity and mortality 4 . Increased C-reactive protein (CRP) has been shown previously to relate to poor outcome after sICH 5 . C-reactive protein (CRP), an acute-phase reactant induced by IL-6, is associated with 30-day mortality in ICH patients 6 . Several prospective studies in ischemic stroke patients have reported that increased levels of acute inflammatory markers, such CRP 7 and white blood cell (WBC) count 8 are associated with increased risk of death or disability. The prognostic role of these inflammatory markers after sICH is less clear 9 . Early neurologic worsening (ENW) in patients with ICH is generally thought to be due to enlargement of the hemorrhage or development of hydrocephalus, whereas late deterioration is linked to perilesional edema 10 . Among the factors related to the poor prognosis of ICH is the size of the hemorrhage itself, intracranial hypertension with cerebral tissue displacement and herniation, and cellular death that occurs hours or days later in the tissues surrounding the hematoma 11 . Potential limitations of previous studies of inflammatory markers in sICH include the possibility that the systemic acute-phase response may have been attributable to accompanying infection in some cases, and that the inflammatory and CRP response could still be evolving. Additionally, changes in CRP levels after acute sICH have not been analyzed in detail, yet these may be more reflective of the inflammatory response to sICH. Therefore, the primary aim of my study was to evaluate the kinetics of plasma CRP concentrations after acute sICH and the relationship with short term clinical outcome.
Methodology
This was prospective cohort study which was conducted in the Department of Neurology at Dhaka Medical College and Hospital, Dhaka, Bangladesh from July 2012 to June 2014 for a period of two (02) years. Patients with spontaneous intracerebral haemorrhage admitted in the departments of Neurology, Neurosurgery and Medicine, Dhaka Medical College and Hospital, Dhaka, Bangladesh were taken as study population. Patients presented with first ever spontaneous intracerebral haemorrhage with the age group of more than or equal to 18 years with both sexes and hospital admission within 48 hours of onset were included for this study. Patients with haematoma secondary to head injury, patients of ischaemic stroke and subarachnoid haemorrhage, patients underwent surgical or interventional procedure, unable to confirm by CT-scan of head, patients presented with serious co-morbidity like chronic kidney disease, heart failure, decompensated chronic liver disease, respiratory failure and metabolic encephalopathy and infection were excluded from this study. Those with sICH were selected for the study, after getting the informed consent. The basic demographic variables and important vascular risk factors were recorded. A detailed history was taken and a meticulous neurological examination was performed in every patient. Patients were considered to have hypertension when there was reliable history of hypertension, hypertensive retinopathy on examination or features of left ventricular hypertrophy in ECG. CT scan of head was done on every patient at the department of radiology and imaging of Dhaka Medical Collegeas early as possible for confirmation of spontaneous intracerebral hemorrhage. Admission plasma CRP was measured in every patient by nephelometric system by using commercial kit (DADE BEHRING BN 100, USA) in the Department of Microbiology, Dhaka Medical Collegeand study population were divided into group I (plasma CRP≥6 mg/L) and group II (plasma CRP<6 mg/L). All the patients received the standard medical management of spontaneous ICH according to the guideline of American Heart Association and American Stroke Association (Morgenstern 2010), as far as practicable. In all patients the plasma CRP concentration was measured within 6 hours of admission (median, 120 minutes) at the time of first blood drawing and before any procedure. The patients were observed daily till 1 week after admission with special attention to vital parameters and clinical outcome which were mortality, functional outcome and early neurological worsening. The patients were observed daily during the first week after onset with special attention to vital parameters like pulse, blood pressure, temperature, respiratory rate and neurological features. The functional outcome and early neurological worsening at the end of first week and any mortality within this period were taken as outcome. GOS 2 to 3, early neurological worsening like deterioration of GCS score by 2 or more at the end of first week and mortality within that period was taken as poor outcome. Finally findings were analyzed and clinical outcome were compared in patient with different level of admission plasma CRP. The analyses were performed by using standard statistical procedures. SPSS version 20.0 were utilized whenever required and also to cross-check the results. The mortality among patients with C-reactive protein positive/elevated (≥6mg/L) was compared to that of patients with C-reactive protein negative/normal (<6mg/L). Early neurological worsening and functional outcome were compared in the same manner. Results were expressed in odds ratio at 95% confidence interval and were considered significant if p value comes 0.05 or less. Prior to the commencement of this study, the research protocol was approved by the Research Review Committee.
Results
The present study was undertaken to test hypothesis that spontaneous intracerebral haemorrhage patients with high admission plasma C-reactive protein usually carry adverse in-hospital short term outcome. To that end a total of 100 patients of sICH with predefined enrollment criteria were included in the study and were subjected test for admission plasma C-reactive protein along with other necessary tests but two patients were dropped due to inadequate follow-up. So, 98 patients were included for the final analysis, of them 37 had plasma C-reactive protein<6mg/L and were consider as normal/negative and the rest 61 had plasma C-reactive protein ≥6mg/L and were considered as having elevated/positive admission C-reactive protein.
In-hospital short term outcome (mortality, functional outcome and early neurological worsening) were then compared between the two groups. Table 1 shows the important baseline prognostic variables of study subjects at admission. No significance difference was found in the baseline prognostic variables between the CRP positive and CRP negative groups. Table 2 shows the overall outcome of spontaneous ICH patients in this study. Early neurological worsening at the end of first week was 37(38%) patients. Poor functional outcome (GOS 2-3) at the end of first week was found in 51(52%) patients. Overall mortality within that period was 16(17%) patients. In hospital functional outcome were observed more adverse in elevated/ positive CRP group at the end of first week and mortality was also observed higher in CRP positive group than CRP negative within that period. Table 3 compares the proportion of GCS score < 9 and Glasgow outcome scale at the end of first week, and early neurological worsening, functional outcome and mortality within that period between CRP positive and negative groups. Elevated CRP level was associated with higher proportion of GCS score < 9 at day seven. Early neurological worsening and poor functional outcome (GOS2-3) was also found more in these patients. Higher mortality was observed too in these patients. Among the patients who survived the first week, the proportion of CRP positive was also higher.
Discussion
Stroke is the second leading cause of death among the non communicable diseases worldwide and the leading cause of long term disability 7 . Overall incidence of ICH is approximately 0.25 per 1000 person-years, higher in the Asians 0.5 per 1000 person-year 11 . Spontaneous ICH is often a devastating clinical event with limited effective therapies. Inflammation is a major feature of sICH pathology, and involve in the progression of brain injury after sICH 9 . Increased CRP has been shown previously to relate to poor outcome after sICH. CRP is an acute-phase reactant induced by IL-6 which is also associated with 30-day mortality in sICH patients 5 . Most of the studies regarding this issue have been conducted in the western countries. In Bangladesh short term outcome in ischemic stroke was studied by CRP response but no such type of study has been conducted in Bangladesh. Considering all these circumstances, C-reactive protein responses on admission after sICH is studied to find out any association with short term clinical outcome and mortality within seven days. Ninety eight patients of spontaneous intracerebral haemorrhage (ICH) were included in this study. Most (84%) of the patients were of 50 years or more age. Mean (± standard deviation) age was 64.01 ± 13.90 years. The age distribution was similar to that of most of the previous studies conducted in Bangladesh and India [12] [13] [14] . The youngest and oldest patients were of 20 and 80 years respectively. Number of males (60%) was more than that of females (40%). Similar sex distribution was found in the study on spontaneous ICH patients in Heerlen, Netherlands 15 . C-reactive protein level was found to be elevated/CRP positive in 62% patients and not elevated/CRP negative in 38% patients out of 98 patients. Median CRP was 8.0 mg/L (R, 4-16 mg/L). These findings are almost consistent with the study conducted by Napoli 2014. Median CRP was 9(R, 7-16) mg/L in the poor functional outcome (GOS 2-3) group which was significant (P<0.001). CRP was also significantly higher (P=0.003) in early neurological worsening patients was 9(R, 7-16 mg/L) compared with stable or improving patients. Baseline prognostic variables of study subjects at admission, SBP 159.6 ± 23.6 mm Hg, DBP 100.5 ± 24.4 mm Hg, GCS score<9 in 53%, Glucose 7.8 ± 1.6 mmol/L, WBC > 11,000/ cu mm in 72%, ICH volume > 60 cc in 15%, Midline shift (>10 mm) in 18% and Ventricular extension in 20% respondents were found respectively in CRP positive tertile none of these were statisticaly significant in comparison to CRP negetive terile. Regarding outcome, early neurological worsening at the end of first week was 38% patients which was higher than the study conducted by Napoli et al 16 . Insufficient advanced stroke care facilities might be the reason behind higher early neurological worsening in this series. Poor functional outcome (GOS 2-3) at the end of first week was found in 52%(n=51) patients. Similar finding was observed in studies on spontaneous intracerebral haemorrhage patients conducted by Napoli et al 16 . Overall mortality within that period was 17% patients which was lower to Napoli et al 6 . Small sample size, short duration and less severe initial presentation of the respondents might be the reason behind lower mortality in this series. The focus of this study, admission plasma CRP level ≥ 6 mg/L and <6 mg/L were found in 62% and 38% patients respectively, which is almost consistent with Napoli et al 16 . In terms of outcome , patients with higher plasma CRP level ≥6 mg/L had increased mortality and poor functional outcome (GOS 2-3) andearly neurological worsening than the patients with plasma CRP level <6 mg/L. Similar findingwas observed in a study conducted by Napoli et al 6 in Italy. Patients with high admission plasma CRP were found to carry 4.6 times (95% CI =1.02 -17.64) higher risk of mortality, 2.57 times (95% CI=1.27 -5.31) higher risk of early neurological worsening and 2.18 times (95% CI = 1.38 -3.42) higher risk of poor functional outcome (GOS 2-3) than those who had lower admission plasma CRP level. But mortality was lower than that of a study by Napoli et al6 and Napoli et al 16 . This descripency was probably due tosmall sample size, short duration and less severe initial neurological deficit of the cases in this seris. Poor functional outcome (GOS 2-3) of the present study was consistent with finding of Napoli et al 6 . Early neurological worsening at the end of first week was higher than the study conducted by Napoli et al 16 . Insufficient advanced stroke care facilities might be the reason behind higher early neurological worsening in this series. A similar relation between admission plasma CRP level and short-term outcome has been observed in 223 patients in Italy by Napoli et al 6 . In this research, it was found that patients with highest tertile of admission plasma CRP were found to carry 4.6 times (95% CI =1.02 -17.64) higher risk of mortality and 2.18 times (95% CI = 1.38 -3.42) higher risk of poor functional outcome(GOS 2-3) than those who had lowest tertile admission plasma CRP level. It also revealed that 2.57 times (95%CI=1.27 -5.31) higher risk of early neurological worsening in the patient with highest tertile of admission plasma CRP.
Conclusion
High admission plasma CRP level may be associated with higher proportions of poor short term outcome (GOS 2-3), early neurological worsening at the end of the first week after onset and mortality within this period in the patients with spontaneous intracerebral haemorrhage. Therefore, the hypothesis of this study is proved. Thus, admission plasma CRP can be used as a reliable predictor of poor short term outcome, early neurological worsening and mortality in patients with spontaneous intracerebral haemorrhage. This may assist patient care and prognostication and may be useful in selecting patients for trials ofanti-inflammatory therapies aimed at preventing early neurological worsening and mortality and thus improving clinical outcome. Admission plasma CRP can be used as reliable predictor of short term clinical outcome in spontaneous intracerebral haemorrhage.
